BMS Spins Off Mead Johnson In IPO, Retaining Majority Control
This article was originally published in The Tan Sheet
Executive Summary
Bristol-Myers Squibb will spin off its Mead Johnson infants and children nutritional products business in an initial public offering of shares rather than sell the unit, the firm says